Skip to content

Study · Not a test of the peptide alone · 1987

5 results

[The immunomodulator thymalin in the experimental chemotherapy of tumors].

Amosova EN, Iaremenko KV, Cherdyntseva NV, Nikolin VP, Ogreba VI

Voprosy onkologii1 Jan 1987

PMID3686911 (opens in a new tab)PepBankPUB-03686911
Publisher pageAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice, thymalin with cytostatic drugs potentiated the drugs' therapeutic effect.

    In plain wordsIn mice, thymalin with cytostatic drugs increased the drugs' therapeutic effect.

    Peptide
    Thymalin
    Outcome
    IncreaseTherapeutic effect of cytostatic drugs
    Study

    mousen: not reported in source

    Inbred and noninbred mice in experimental tumor chemotherapy
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    Experiments on inbred and noninbred mice showed thymalin to potentiate the therapeutic effect of cytostatic drugs.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice receiving experimental tumor chemotherapy, thymalin treatment was followed by tumor growth inhibition.

    In plain wordsIn mice receiving tumor chemotherapy, thymalin treatment was followed by reduced tumor growth.

    Peptide
    Thymalin
    Outcome
    DecreaseTumor growth
    Study

    mousen: not reported in source

    Inbred and noninbred mice in experimental tumor chemotherapy
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    Thymalin treatment was followed by inhibition of tumor growth and dissemination, increase in the animal's life span and amelioration of antitumor drug-induced immunodepression.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice receiving experimental tumor chemotherapy, thymalin treatment was followed by inhibited tumor dissemination.

    In plain wordsIn mice receiving tumor chemotherapy, thymalin treatment was followed by reduced tumor spread.

    Peptide
    Thymalin
    Outcome
    DecreaseTumor dissemination
    Study

    mousen: not reported in source

    Inbred and noninbred mice in experimental tumor chemotherapy
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    Thymalin treatment was followed by inhibition of tumor growth and dissemination, increase in the animal's life span and amelioration of antitumor drug-induced immunodepression.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice receiving experimental tumor chemotherapy, thymalin treatment was followed by increased life span.

    In plain wordsIn mice receiving tumor chemotherapy, thymalin treatment was followed by longer life span.

    Peptide
    Thymalin
    Outcome
    IncreaseLife span
    Study

    mousen: not reported in source

    Inbred and noninbred mice in experimental tumor chemotherapy
    Outcome group
    Mortality · Whole body

    Source sentences

    Summary
    Thymalin treatment was followed by inhibition of tumor growth and dissemination, increase in the animal's life span and amelioration of antitumor drug-induced immunodepression.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  5. 05AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice receiving experimental tumor chemotherapy, thymalin treatment ameliorated antitumor drug-induced immunodepression.

    In plain wordsIn mice receiving tumor chemotherapy, thymalin treatment reduced drug-related immune suppression.

    Peptide
    Thymalin
    Outcome
    DecreaseAntitumor drug-induced immunodepression
    Study

    mousen: not reported in source

    Inbred and noninbred mice in experimental tumor chemotherapy
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymalin treatment was followed by inhibition of tumor growth and dissemination, increase in the animal's life span and amelioration of antitumor drug-induced immunodepression.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.